Drug safety and pharmacovigilance

Drug safety and pharmacovigilance

What are IME listings?

This article provides an overview of Important Medical Event (IME) listings, their development, and their role in pharmacovigilance.

Bala

Read

Drug safety and pharmacovigilance

Compliance for Beginners: Pharmacovigilance

This article simplifies key compliance concepts, highlights practical do’s and don’ts, and provides essential insights to help case processors and newcomers.

Bala

Read

Drug safety and pharmacovigilance

Regulatory intelligence

In today’s rapidly evolving compliance landscape, Regulatory Intelligence has emerged as a strategic necessity rather than a back-office function.

Bala

Read

Drug safety and pharmacovigilance

🥶 Adverse Drug Reactions vs Adverse Event: The differences

In this blog, we address the common confusion between adverse reactions and adverse events. We aim to clarify the distinction between these terms that often perplex many individuals. If you are still uncertain about the difference, this blog provides the perfect opportunity to gain clarity and enhance your understanding.

Bala

Read

Drug safety and pharmacovigilance

Subjects in Clinical Studies: Explained

In this comprehensive article, you’ll discover who the key term by subjects in clinical studies. Let’s dive in and explore.

Bala

Read

Drug safety and pharmacovigilance

Key Departments and Roles in Pharmacovigilance

This comprehensive article highlights the core departments that are essential for the smooth and effective functioning of a pharmacovigilance (PV) department.

Bala

Read

Drug safety and pharmacovigilance

Adverse Event Reporting: How to Do It Right

This article explains the importance of adverse event reporting to how to further process for effective submission reports to regulatory authorities.

Bala

Read

Drug safety and pharmacovigilance

Pharmacovigilance System Master File: A Complete Overview

This blog provides a clear and concise overview of pharmacovigilance system master file the essential components, regulatory expectations, maintenance practices.

Bala

Read